OptimizeRx opens EHR inventory to programmatic pharma buyers
OptimizeRx has launched programmatic access for pharmaceutical advertisers to authenticated electronic health record (EHR) inventory. This new offering allows life sciences marketers to reach healthcare professionals (HCPs) through mainstream demand-side platforms (DSPs), tapping into a pharma ad market valued at over $19 billion.
Key Takeaways
- Authenticated EHR ad inventory is now available through DSP platforms.
- OptimizeRx says the inventory is bot-free and tied to authenticated EHR environments.
- Life sciences marketers can use programmatic buying to reach healthcare professionals (HCPs).
- The company is targeting a pharma ad market valued at more than $19 billion.
Why It Matters
This puts a new authenticated EHR supply path into the same programmatic stack that ad buyers already use for other digital media. For pharma advertisers, the immediate change is access to HCP inventory inside doctors’ workflows through mainstream DSPs, rather than a separate buying channel. For the broader monetization stack, it shows healthcare publishers can package authenticated inventory for programmatic demand. What to watch next is whether OptimizeRx discloses actual DSP integrations or any measurement details around HCP reach.
Read full article at stocktitan.net
Get this in your inbox → Subscribe
Enjoy our coverage?
Add StreamingMeme as a preferred source on Google to see more of our streaming news at the top of your Search results.
Add as preferred source